NP / PA
Riverside Family Health LLC
Riverside Family Health LLC was paid $3.31M by Medicaid between Jan 2018 and Dec 2024, across 79 billing codes. Its largest line is 99215, doctor's office visit, returning patient (complex) — 43% of everything it billed.
33Billing provider infoRIVERSIDE FAMILY HEALTH LLC
DECATUR, AL 35601
DECATUR, AL 35601
33aNPI1851652416assigned 05/30/2012
33bProvider typeFamily Nurse Practitioner
28Total paid$3.31M
24GClaims109,406
24DCodes billed79
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Alabama
Rank by total paid#2 of 130
Median peer was paid$0.00
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,920 | $360K | |
| 2019 | 12,838 | $420K | |
| 2020 | 13,683 | $481K | |
| 2021 | 20,318 | $647K | |
| 2022 | 20,218 | $549K | |
| 2023 | 18,269 | $457K | |
| 2024incomplete | 13,160 | $395K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 43% | 14,763 | 12,517 | $1.44M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 4,994 | 4,426 | $383K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10% | 7,093 | 6,149 | $344K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.2% | 3,686 | 3,296 | $172K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.8% | 3,510 | 3,121 | $158K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.1% | 5,735 | 5,071 | $135K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.2% | 2,211 | 2,037 | $107K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.6% | 1,155 | 1,052 | $54K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 1,428 | 1,215 | $50K |
| 90686 | 1.3% | 2,557 | 2,313 | $42K | |
| 87430 | 1.1% | 2,923 | 2,633 | $36K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,461 | 2,259 | $32K |
67 more codes
| 90647 | <1% | 1,708 | $31K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 636 | $27K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,152 | $26K |
| 90670 | <1% | 1,408 | $25K | |
| 90723 | <1% | 1,038 | $19K | |
| 87634 | <1% | 426 | $19K | |
| 81002 | <1% | 6,654 | $17K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 546 | $15K |
| 90680 | <1% | 786 | $14K | |
| 90633 | <1% | 731 | $13K | |
| 99401 | <1% | 1,441 | $12K | |
| 87899 | <1% | 943 | $11K | |
| 96127 | <1% | 5,151 | $11K | |
| 90707 | <1% | 583 | $11K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,043 | $11K |
| 90716 | <1% | 601 | $11K | |
| 90671 | <1% | 491 | $9K | |
| 81003 | <1% | 2,868 | $7K | |
| 99173 | <1% | 4,209 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 789 | $7K |
| 83655 | <1% | 501 | $7K | |
| 87503 | <1% | 531 | $5K | |
| 90651 | <1% | 252 | $4K | |
| 99001 | <1% | 1,771 | $4K | |
| 90734 | <1% | 167 | $3K | |
| 82948 | <1% | 1,012 | $3K | |
| 87807 | <1% | 282 | $3K | |
| 85014 | <1% | 6,150 | $3K | |
| 94060 | <1% | 127 | $3K | |
| 94150 | <1% | 448 | $2K | |
| 90648 | <1% | 104 | $2K | |
| 90658 | <1% | 108 | $2K | |
| 82962 | <1% | 727 | $2K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 39 | $2K |
| 90620 | <1% | 57 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,511 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 251 | $950.40 |
| 90715 | <1% | 58 | $887.95 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 112 | $848.00 |
| 86308 | <1% | 105 | $581.80 | |
| 94010 | <1% | 59 | $570.00 | |
| 90685 | <1% | 55 | $554.12 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 698 | $467.69 |
| 90696 | <1% | 29 | $435.38 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 26 | $351.10 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 13 | $300.28 |
| 90381 | <1% | 13 | $257.27 | |
| 90700 | <1% | 12 | $217.69 | |
| 36416 | <1% | 466 | $140.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,092 | $120.00 |
| 81025 | <1% | 27 | $66.65 | |
| 92551 | <1% | 32 | $29.20 | |
| 97802 | 0% | 557 | $0.00 | |
| D0140 | Limited oral evaluation - problem focused | 0% | 279 | $0.00 |
| 96161 | 0% | 509 | $0.00 | |
| 94760 | 0% | 643 | $0.00 | |
| D1206 | Topical application of fluoride varnish | 0% | 437 | $0.00 |
| S8110 | Peak expiratory flow rate (physician services) | 0% | 166 | $0.00 |
| D1330 | 0% | 57 | $0.00 | |
| D1310 | 0% | 48 | $0.00 | |
| 96150 | 0% | 102 | $0.00 | |
| 91307 | 0% | 53 | $0.00 | |
| 94761 | 0% | 29 | $0.00 | |
| H0049 | Alcohol and/or drug screening | 0% | 86 | $0.00 |
| D0145 | Oral evaluation for a patient under three years of age | 0% | 957 | $0.00 |
| 99188 | 0% | 909 | $0.00 | |
| 0073A | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLANDRUM, CRYSTAL (CEO)